Cargando…
Barrier function and microbiotic dysbiosis in atopic dermatitis
Atopic dermatitis (AD) or atopic eczema is the common inflammatory skin disorder, the prevalence of which has considerably increased during the last 30 years. It affects 15%–30% of children and 2%–10% of adults. AD characteristically alternates between periods of exacerbation or flares and periods o...
Autores principales: | Seite, Sophie, Bieber, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576901/ https://www.ncbi.nlm.nih.gov/pubmed/26396539 http://dx.doi.org/10.2147/CCID.S91521 |
Ejemplares similares
-
Burden of Disease, Unmet Needs in the Diagnosis and Management of Atopic Dermatitis: An Indian Expert Consensus
por: Rajagopalan, Murlidhar, et al.
Publicado: (2021) -
Management of Atopic Dermatitis in Adults in Saudi Arabia: Consensus Recommendations from the Dermatological Expert Group
por: Alakeel, Abdullah, et al.
Publicado: (2022) -
Recommendations for managing cutaneous disorders associated with advancing age
por: Humbert, Philippe, et al.
Publicado: (2016) -
Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel
por: Bensadoun, René-Jean, et al.
Publicado: (2013) -
Cutaneous dysbiosis may amplify barrier dysfunction in patients with atopic dermatitis
por: Hammond, Margaret, et al.
Publicado: (2022)